Results of the TAILORx study are practice changing
Sara M. Tolaney, MD, MPH, talks about whether the results of the TAILORx study in HR+, HER2-, node-negative, intermediate 21-gene recurrence score patients are practice changing at ASCO 2018.
Author: obr
Added: 07/19/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts